Paul Grevitt

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 3

Top Topics

Small Cell Lung Cancer

Signaling Pathway

Radiation Induced

Mitochondrial Dna

Top Venues

EMBO molecular medicine

Cell death & disease

Nature metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Hongmei Fu, Juho Vuononvirta, Silvia Fanti, Fabrizia Bonacina, Antonio D'Amati, Guosu Wang, Thanushiyan Poobalasingam, Maria Fankhaenel, Davide Lucchesi, Rachel Coleby, David Tarussio, Bernard Thorens, Robert J Hearnden, M Paula Longhi, Paul Grevitt, Madeeha H Sheikh, Egle Solito, Susana A Godinho, Michele Bombardieri, David M Smith, Dianne Cooper, Asif Jilani Iqbal, Jeffrey C Rathmell, Samuel Schaefer, Valle Morales, Katiuscia Bianchi, Giuseppe Danilo Norata, Federica M Marelli-Berg
The glucose transporter 2 regulates CD8 + T cell function via environment sensing. Nature metabolism (2023)
Kathryn Davidson, Paul Grevitt, María F Contreras-Gerenas, Katherine S Bridge, Miguel Hermida, Kunal M Shah, Faraz K Mardakheh, Mark Stubbs, Rosemary Burke, Pedro Casado, Pedro Rodriguez Cutillas, Sarah A Martin, Tyson V Sharp
Targeted therapy for LIMD1-deficient non-small cell lung cancer subtypes. Cell death & disease 12 (11) (2021)
Daniel E Foxler, Katherine S Bridge, John G Foster, Paul Grevitt, Sean Curry, Kunal M Shah, Kathryn M Davidson, Ai Nagano, Emanuala Gadaleta, Hefin I Rhys, Paul T Kennedy, Miguel A Hermida, Ting-Yu Chang, Peter E Shaw, Louise E Reynolds, Tristan R McKay, Hsei-Wei Wang, Paulo S Ribeiro, Michael J Plevin, Dimitris Lagos, Nicholas R Lemoine, Prabhakar Rajan, Trevor A Graham, Claude Chelala, Kairbaan M Hodivala-Dilke, Ian Spendlove, Tyson V Sharp
A HIF-LIMD1 negative feedback mechanism mitigates the pro-tumorigenic effects of hypoxia. EMBO molecular medicine 10 (8) (2019)